基本信息
浏览量:417
职业迁徙
个人简介
Neil E. Kay, M.D., is a Professor of Medicine at the Mayo Clinic College of Medicine and a Consultant in the Department of Internal Medicine, Division of Hematology at Mayo Clinic in Rochester, Minnesota. Dr. Kay received his medical degree from the University of Manitoba Medical School in Winnipeg, Manitoba, Canada. He is board certified in Internal Medicine and Hematology.
Dr. Kay is a member of the American Society of Hematology, the Eastern Cooperative Oncology Group, and the National Cancer Institute's Chronic Lymphocytic Leukemia Research Consortium.
Dr. Kay's primary area of interest is in the biological pathogenesis of Chronic Lymphocytic Leukemia and has been working on this aspect for more than 30 years. His work has led to the refinement of CLL prognostic staging indicators using molecular biologic and genetic techniques to more accurately determine individual patient outcomes and promising therapeutic agents to treat the disease. His work, and the work of others, has advanced the ability to counsel CLL patients about their risk of progression. These advances are more relevant to our understanding of the disease and have helped in the development of some unique treatment options. Treatment options arising from this work include, use of epigallocatechin-3 gallate (EGCG) a chemical found in green tea which appears to block VEGF from binding and is now in clinical trials for use in early stage CLL; or use of combination chemoimmunotherapy regimens such as pentostatin, cyclophosphamide and rituximab (PCR); or PCR plus other agents such as anti-VEGF antibodies (bevacizumab or revlimid). More recently he and his team at Mayo are working on the development of mimicking the microenvironment in the laboratory setting so as to better study the impact of drugs and other agents on the survival of CLL B-cells. In this way there will be a more realistic approach to determining efficacy of single or combination agents in the treatment of CLL patients.
Dr. Kay is the principal investigator on several clinical trials and research grants focused on this disease. Some of his more recent publications of his work include: "CD49d expression is an independent predictor of overall survival in patients with chronic lymphocytic leukaemia: a prognostic parameter with therapeutic potential." Br J Haematol. 2008; "MBL or CLL: which classification best categorizes the clinical course of patients with an absolute lymphocyte count >or= 5 x 10(9) L(-1) but a B-cell lymphocyte count <5 x 10(9) L(-1)?" Leuk Res. 2008; "Aberrant regulation of pVHL levels by microRNA promotes the HIF/VEGF axis in CLL B-cells." Blood. 2009; "Phase I Trial of Daily Oral Polyphenon E in Patients with Asymptomatic Rai Stage 0 to II Chronic Lymphocytic Leukemia." J Clin Oncol. 2009.
研究兴趣
论文共 619 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Juan G Ripoll,Sidna M Tulledge-Scheitel, Anthony A Stephenson,Shane Ford, Marsha L Pike,Ellen K Gorman,Sara N Hanson,Justin E Juskewitch, Alex J Miller, Solomiia Zaremba,Erik A Ovrom,Raymund R Razonable,
mBiopp.e0040024-e0040024, (2024)
Haematologica (2024)
Geffen Kleinstern, Nicholas J. Boddicker, Daniel R. O’Brien,Cristine Allmer,Kari G. Rabe,Aaron D. Norman, Rosalie Griffin,Huihuang Yan,Tao Ma,Timothy G. Call,Laura Bruins,Sochilt Brown,
Blood Advances (2024)
Ethan J. Katcher, Kim A. Gwin,Sameer A. Parikh,Kari G. Rabe,Petra K. Lothert,Preeti Trisal,Esteban Braggio,Susan L. Slager, Nicholas Strong,Daniel L. Van Dyke,Zhiquan Wang, C. Chris Huang,
Cancer Researchno. 7_Supplement (2024)
Blood (2024)
Raphael Mwangi,Dennis P. Robinson,Sara J. Achenbach,Geffen Kleinstern,Aaron D. Norman,Kari G. Rabe,Janet E. Olson,Neil E. Kay, Rosalie Griffin, Nicholas J. Boddicker,Esteban Braggio,Sameer A. Parikh,
Cancer Researchno. 6_Supplement (2024): 6152-6152
Cancer Researchno. 6_Supplement (2024): 7450-7450
JACC: CardioOncologyno. 2 (2024): 251-263
BLOODno. 1 (2024): 57-63
Jessica Bordini, Chiara Lenzi,Michela Frenquelli, Alessia Morabito, Athanasios Pseftogas,Daniela Belloni,Larry Mansouri,George Tsiolas, Eleonora Perotta,Pamela Ranghetti, Francesca Gandini, Francesca Genova,
Leukemiapp.1-12, (2024)
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn